1. Home
  2. MXCT vs ATOM Comparison

MXCT vs ATOM Comparison

Compare MXCT & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • ATOM
  • Stock Information
  • Founded
  • MXCT 1999
  • ATOM 2001
  • Country
  • MXCT United States
  • ATOM United States
  • Employees
  • MXCT N/A
  • ATOM N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ATOM Semiconductors
  • Sector
  • MXCT Health Care
  • ATOM Technology
  • Exchange
  • MXCT Nasdaq
  • ATOM Nasdaq
  • Market Cap
  • MXCT 159.9M
  • ATOM 155.4M
  • IPO Year
  • MXCT 2021
  • ATOM 2016
  • Fundamental
  • Price
  • MXCT $1.76
  • ATOM $4.86
  • Analyst Decision
  • MXCT Buy
  • ATOM
  • Analyst Count
  • MXCT 4
  • ATOM 0
  • Target Price
  • MXCT $7.50
  • ATOM N/A
  • AVG Volume (30 Days)
  • MXCT 841.1K
  • ATOM 552.3K
  • Earning Date
  • MXCT 11-05-2025
  • ATOM 10-28-2025
  • Dividend Yield
  • MXCT N/A
  • ATOM N/A
  • EPS Growth
  • MXCT N/A
  • ATOM N/A
  • EPS
  • MXCT N/A
  • ATOM N/A
  • Revenue
  • MXCT $35,754,000.00
  • ATOM $49,000.00
  • Revenue This Year
  • MXCT N/A
  • ATOM N/A
  • Revenue Next Year
  • MXCT $14.80
  • ATOM $700.00
  • P/E Ratio
  • MXCT N/A
  • ATOM N/A
  • Revenue Growth
  • MXCT N/A
  • ATOM N/A
  • 52 Week Low
  • MXCT $1.26
  • ATOM $3.06
  • 52 Week High
  • MXCT $5.20
  • ATOM $17.55
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 57.62
  • ATOM 58.26
  • Support Level
  • MXCT $1.52
  • ATOM $4.20
  • Resistance Level
  • MXCT $1.84
  • ATOM $5.24
  • Average True Range (ATR)
  • MXCT 0.11
  • ATOM 0.41
  • MACD
  • MXCT 0.02
  • ATOM 0.03
  • Stochastic Oscillator
  • MXCT 79.22
  • ATOM 68.47

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About ATOM Atomera Incorporated

Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.

Share on Social Networks: